DERIDDER, La., Sept. 21, 2017 -- AMERISAFE, Inc. (Nasdaq:AMSF), a specialty provider of hazardous workers’ compensation insurance, announced today that it will release its 2017 third quarter financial results on Wednesday, October 25, 2017 after the market closes. In conjunction with the release, the Company has scheduled a conference call which will be broadcast live over the Internet on Thursday, October 26, 2017 at 10:30 a.m. Eastern time.
| What: | AMERISAFE Third Quarter 2017 Earnings Conference Call |
| When: | Thursday, October 26, 2017 at 10:30 a.m. Eastern time / 9:30 a.m. Central time |
| How: | Live via phone – By dialing 720-545-0027, or live over the Internet – by logging onto the web at the address below |
| Where: | http://www.amerisafe.com, on the “Investor Home” page of the “Investor Relations” section of the Company’s website |
For those who cannot listen to the live call, a telephonic replay will be available through November 3, 2017 and may be accessed by calling 855-859-2056 or 404-537-3406 and using the pass code 88043900#. An archive of the webcast will be available after the call for a period of 60 days in the “Investor Relations” section of the Company’s website.
About AMERISAFE
AMERISAFE, Inc. is a specialty provider of workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, manufacturing, and agriculture. AMERISAFE actively markets workers’ compensation insurance in 27 states.
| Contact: | Neal A. Fuller, EVP & CFO |
| AMERISAFE, Inc. | |
| 337-463-9052 |


Hanwha Signals Readiness to Build Nuclear-Powered Submarines at Philly Shipyard for U.S. Navy
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Italy Fines Apple €98.6 Million Over App Store Dominance
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 



